Wang Rui, Lv Jingnan, Chen Liang, Zhao Yanan, Du Hong
Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, China.
MOE Key Laboratory of Geriatric Diseases and Immunology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu China.
PLoS Pathog. 2025 Sep 11;21(9):e1013456. doi: 10.1371/journal.ppat.1013456. eCollection 2025 Sep.
Antifungal persistence is the phenomenon that occurs when a subpopulation of fungal cells can survive in the presence of high concentrations of antifungal drugs, which is different from the concepts of antifungal resistance and tolerance. Fungal persisters are not mutants but phenotypic variants of normal cells, entering a dormant state with low metabolism and proliferation. Previous studies have shown that antifungal persistence may lead to therapeutic failure, as well as chronic or recurrent fungal infections in clinical settings. This review provides a comprehensive overview of antifungal persistence covering its definition, distinctions from other related concepts, detection methods, and molecular mechanisms of formation. Importantly, we discuss relevant in vivo experiments and clinical observations to assess clinical relevance of antifungal persistence.
抗真菌持留是指在高浓度抗真菌药物存在的情况下,真菌细胞亚群能够存活的现象,这与抗真菌耐药性和耐受性的概念不同。真菌持留菌不是突变体,而是正常细胞的表型变体,进入低代谢和低增殖的休眠状态。先前的研究表明,抗真菌持留可能导致治疗失败,以及临床环境中的慢性或复发性真菌感染。本综述全面概述了抗真菌持留,涵盖其定义、与其他相关概念的区别、检测方法以及形成的分子机制。重要的是,我们讨论了相关的体内实验和临床观察,以评估抗真菌持留的临床相关性。